Stop Guessing. Start Forecasting. Use MEDDIC.

Sales forecasting gets a bad reputation because too often it turns into educated guessing. Reps are optimistic by nature. Managers want confidence. Somewhere in the middle, numbers get inflated and reality shows up at the end of the quarter.

The real issue is that most forecasts are based on feelings instead of evidence.

MEDDIC gives you a much better way to forecast because it forces you to evaluate deals based on what the customer has actually confirmed. When you use MEDDIC correctly, every opportunity starts sending signals about how real it is and how likely it is to close.

The trick is translating those signals into your forecast categories.

You should be using MEDDIC to decide whether a deal belongs in Pipeline, Best Case, or Commit. Each category represents a different level of confidence based on how much of MEDDIC you have validated.

Think of it like building a case in a courtroom. The more evidence you have, the stronger your prediction becomes.

Let’s walk through how to do this practically.

Start with Pipeline.

Pipeline deals are opportunities you are actively working but still developing. You believe there might be a fit, but you have not yet validated enough MEDDIC elements to confidently predict the outcome.

These deals are still in discovery mode.

Maybe you have had a good conversation. Maybe the prospect seems interested. But interest alone is not enough to forecast.

In Pipeline deals you are often still trying to understand the real problem or determine whether the problem is meaningful enough to drive change.

If you have not clearly confirmed the customer’s pain or you do not yet understand how they will make the decision, the opportunity belongs in Pipeline.

Pipeline is where most early opportunities should live. Your job at this stage is to gather MEDDIC evidence. You are working to uncover the business pain, understand how decisions get made, and identify who inside the organization can help move things forward.

Once you start validating those elements, the deal may graduate to Best Case.

Best Case deals have real traction. The opportunity is no longer speculative. You have confirmed enough information to believe the deal has legitimate potential to close.

But it is still not fully controlled.

For a deal to belong in Best Case, there should be a minimum MEDDIC foundation already in place.

At the very least, you should have confirmed three things.

First, you have clearly identified the customer’s pain. The problem must be real, meaningful, and acknowledged by the buyer.

Second, you understand the Decision Criteria. You know what factors will determine which vendor they select and how your solution aligns with those priorities.

Third, you have at least one additional MEDDIC element validated. That could be access to a Champion, insight into the Decision Process, visibility into Metrics, or some level of connection to the Economic Buyer.

This combination tells you the opportunity is more than a casual conversation. The buyer has a problem, they are evaluating solutions, and you have visibility into how the decision will happen.

That is what moves a deal into Best Case.

These deals typically fall somewhere around sixty to eighty percent probability. They feel strong, but there are still risks. Maybe you have not yet engaged the executive sponsor. Maybe the internal buying process still has some uncertainty.

Best Case deals have momentum, but they are not locked in.

Commit deals are different.

Commit deals should represent the opportunities you genuinely expect to close. These deals should carry ninety percent or greater confidence, and that confidence should be based on clear MEDDIC evidence.

To move a deal into Commit, there should be a minimum of four MEDDIC elements validated, and certain ones are especially important.

You must have clearly identified the customer’s pain. Without a compelling problem, deals stall.

You must understand the Decision Criteria so you know exactly what the buyer cares about and why your solution fits.

You must have either access to the Economic Buyer or a strong Champion who has influence with that executive.

And you must have some form of Metrics tied to the business impact. The buyer should understand the value in measurable terms such as revenue growth, cost reduction, risk mitigation, or operational efficiency.

When those four pieces are present, the deal becomes far more predictable.

At this point you are no longer guessing about the outcome. The buyer has a real problem, understands the value, and someone inside the organization is helping drive the purchase.

Most Commit deals will also have the remaining MEDDIC elements validated as well. You typically understand the decision process and the timeline. But the four elements above create the minimum foundation that gives you high confidence.

A Commit deal should sound extremely concrete when you describe it.

You should be able to explain the problem, the business impact, who will approve the purchase, and why your solution meets their criteria.

For example, imagine describing a deal like this.

“The VP of Operations confirmed their manual workflow is costing them roughly one million dollars annually in labor inefficiency. Reducing that cost is their top priority this quarter. Our solution matches the three decision criteria they outlined which are automation, reporting visibility, and integration with their existing platform. Our Champion is the Director of Operations who is presenting our proposal to the CFO next week.”

That level of clarity is what makes a deal Commit worthy.

If you cannot clearly explain the pain, the value, the criteria, and who is driving the decision, the deal probably belongs in Best Case instead.

Here is a simple weekly discipline you can use to improve your forecast.

When reviewing each opportunity, ask yourself four questions.

Have I clearly identified the customer’s pain? Do I understand the decision criteria? Is there either an Economic Buyer connection or a real Champion? Have we tied the solution to measurable business metrics?

If the answer to those questions is no, the deal likely belongs in Pipeline.

If you have confirmed the pain, the decision criteria, and at least one additional MEDDIC element, the deal can move into Best Case.

If you have confirmed the pain, the decision criteria, a Champion or Economic Buyer, and clear metrics tied to business value, the deal may be strong enough to Commit.

This approach does something powerful for your forecasting.

It removes optimism and replaces it with evidence.

Instead of saying a deal “feels good,” you are evaluating real buying signals. Over time that discipline changes how you sell. You start asking better discovery questions. You focus on understanding the buying process. You work harder to build Champions and quantify value.

And something else happens as well.

Your forecast starts becoming accurate.

MEDDIC is often taught as a qualification framework, but one of its greatest strengths is predictability. When you use MEDDIC to categorize your deals into Pipeline, Best Case, and Commit, you turn forecasting into a structured evaluation of the customer’s buying reality.

That is when forecasting stops being stressful and starts becoming reliable.